December 12, 2013 10:30 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
In a report published Thursday, Credit Suisse analyst V. Divan reiterated an Outperform rating on
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
(NYSE: AGN), and raised the price target from $104.00 to $112.00.In the report, Credit Suisse noted, “Increasing conviction on AGN heading into 2014. AGN has been our most debated Outperform pharma call since our initiation. We sense many investors are parked on the sidelines awaiting better clarity on some controversies surrounding the name. Proprietary insights and deep-dive work on these leave us increasingly bullish on the name. We reiterate Outperform and increase TP to $112 (from $104), while increasing EPS estimates for 2014 and beyond.”Allergan closed on Wednesday at $95.65.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.